CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | GOEDDEL DAVID V Director | Purchase | +2,222,222 | $4.50 | $10.0M | 13,599,275 |
| 2023-08-29 | Hoey Timothy Chief Scientific Officer | Sale 10b5-1 | −7,243 | $4.26 | $31K | 247,396 |
| 2023-08-16 | Hoey Timothy Chief Scientific Officer | Sale | −4,007 | $3.81 | $15K | 254,639 |
| 2023-08-16 | Tingley Whittemore Chief Medical Officer | Sale | −5,563 | $3.81 | $21K | 76,437 |
| 2023-08-16 | PATTERSON LEONE D Chief Fin. and Bus. Officer | Sale | −4,452 | $3.81 | $17K | 64,542 |
| 2023-08-16 | Ali Faraz Chief Executive Officer | Sale | −5,563 | $3.81 | $21K | 119,437 |
| 2023-06-09 | Walsh Jeffrey T. Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Williams R Sanders Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Stehman-Breen Catherine Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Srivastava Deepak Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Lee June Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | GOEDDEL DAVID V Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | CHEN JIN-LONG Director | Grant or award · Stock Option (Right to buy) | +29,532 | 29,532 | ||
| 2023-06-09 | Burroughs Amy L. Director | Grant or award · Stock Option (Right to buy) | +14,766 | 14,766 | ||
| 2023-03-10 | COLUMN GROUP III GP, LP 10% owner | Purchase | +6,779 | $2.60 | $18K | 11,377,053 |
| 2023-03-10 | GOEDDEL DAVID V Director | Purchase | +6,779 | $2.60 | $18K | 11,377,053 |
| 2023-02-15 | Hoey Timothy Chief Scientific Officer | Grant or award | +30,000 | 228,646 | ||
| 2023-02-15 | Hoey Timothy Chief Scientific Officer | Grant or award | +30,000 | 258,646 | ||
| 2023-02-15 | Hoey Timothy Chief Scientific Officer | Grant or award · Stock Option (Right to buy) | +175,000 | 175,000 |
Page 8 of 12 · 228 trades